The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4'-((1R,3r)-3-((R)-2-methylpyrrolidin-1-yl)cyclobutyl)biphenyl-4-carbonitrile ID: ALA4516622
PubChem CID: 11973711
Max Phase: Preclinical
Molecular Formula: C22H24N2
Molecular Weight: 316.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H]1CCCN1[C@H]1C[C@H](c2ccc(-c3ccc(C#N)cc3)cc2)C1
Standard InChI: InChI=1S/C22H24N2/c1-16-3-2-12-24(16)22-13-21(14-22)20-10-8-19(9-11-20)18-6-4-17(15-23)5-7-18/h4-11,16,21-22H,2-3,12-14H2,1H3/t16-,21-,22-/m1/s1
Standard InChI Key: DQUUMUHVZGIZNI-NPFVIJTESA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
22.0191 -3.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0179 -3.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7327 -4.4026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4491 -3.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4462 -3.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7309 -2.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1562 -2.7449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8724 -3.1564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5849 -2.7419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5821 -1.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8611 -1.5064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1517 -1.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3060 -4.3985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5093 -4.1843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2952 -4.9811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0919 -5.1952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5803 -5.3930 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8279 -5.0589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2754 -5.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6874 -6.3864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4944 -6.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6563 -4.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2914 -1.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0038 -1.0857 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 13 1 0
13 2 1 1
15 17 1 6
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 1 0
18 22 1 1
23 24 3 0
10 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 316.45Molecular Weight (Monoisotopic): 316.1939AlogP: 4.96#Rotatable Bonds: 3Polar Surface Area: 27.03Molecular Species: BASEHBA: 2HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.06CX LogP: 4.85CX LogD: 2.25Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.80Np Likeness Score: -0.45
References 1. Łażewska D, Kaleta M, Schwed JS, Karcz T, Mogilski S, Latacz G, Olejarz A, Siwek A, Kubacka M, Lubelska A, Honkisz E, Handzlik J, Filipek B, Stark H, Kieć-Kononowicz K.. (2017) Biphenyloxy-alkyl-piperidine and azepane derivatives as histamine H3 receptor ligands., 25 (20): [PMID:28797771 ] [10.1016/j.bmc.2017.07.058 ]